Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma

• Status: Recruiting
• Trial end date: 2025-06-01

Summary

This research study is studying a drug as a possible treatment for High Grade Meningioma.

• Phase: N/A

Details

• Lead Sponsor: Beijing Tiantan Hospital